Results

Total Results: 1,998 records

Showing results for "discussion".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
    September 07, 2012 - The methodologic problems with these studies are addressed in the Discussion chapter. … Peer Reviewer #1 Discussion The future research section is one of the strongest parts. … Peer Reviewer #4 Discussion The discussion and conclusion section, especially the latter, do not provide … Thank you Peer Reviewer #8 Discussion The discussion is clear and the conclusions are justified based … Peer Reviewer #8 Discussion Page 71: the table is listed as “table 3.” Is that correct?
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
    January 27, 2016 - Discussion/ Conclusion: There is only 1 study assessing bacterial resistance. … I don’t think this test should be lumped in with the discussion of CRP and procalcitonin. … Peer Reviewer #6 (TEP Reviewer) Discussion/ Conclusion; General Comment -Overall the discussion … Please see revised discussion. 195. … Peer Reviewer #13 (Peer Reviewer) Discussion/ Conclusion; General Comment The discussion section
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
    August 31, 2017 - We added a discussion of the black box warning on page 46 of the discussion. … discussion is clear and useful. … The discussion included the important literature. … Peer Reviewer # 3 Discussion The discussion section has some useful ideas but is thin. … We added this point to the discussion. We thank reviewer.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
    July 17, 2013 - Peer Reviewer #1 Discussion/ Conclusion Again, all well done. Thank you for the comment. … Methods, Results, and Discussion, of ES and Full Report, and Conclusions of Full Report, revised to … This limitation of the review is noted in the Discussion section. … The Discussion of Key Question 2 has been substantially revised for greater clarity. … Report authors and AHRQ agreed upon table format after discussion.
  5. effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
    March 01, 2021 - Key Informant #2 Discussion and Conclusions 1. … Key Informant #2 Discussion and Conclusions 2. … Key Informant #2 Discussion and Conclusions 4. … Key Informant #2 Discussion and Conclusions 5. … Key Informant #4 Discussion and Conclusions f.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - Methods Consider more discussion on the potential for bias in the included observational studies. … ” and the discussion on pp. 43-44 seems to agree. … Summary and Discussion In tables 28 & 29, it is unclear what the “-“ represent. … Summary and Discussion In the “Future Research” section it is unclear how these were derived. … Summary and Discussion Fine… no problems. Thank you.
  7. effectivehealthcare.ahrq.gov/sites/default/files/cer-234-headaches-pregnancy-revised-comments.pdf
    November 12, 2020 - • Reviewers also suggested additions to the Discussion section such as limitations (in the literature … EPC authors added those details to the Discussion.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-revised-comments.pdf
    November 12, 2020 - • Reviewers also suggested additions to the Discussion section such as limitations (in the literature … EPC authors added those details to the Discussion.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
    December 16, 2014 - Pg. 3 Much clearer discussion of clinical versus pathologic staging. … P 58 (and discussion). … Peer Reviewer 1 Discussion and Conclusion See General comments. … TEP Reviewer 1 Discussion and Conclusion Yes, clearly stated. … Pg. 83 We agree and have noted this in the Discussion.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-207-ptsd-disposition-comments.pdf
    May 17, 2018 - Peer Reviewer 2 Discussion Again, there are two aspects for future research. … Reliability and a priori naming of the outcome Peer Reviewer 3 Discussion The discussion … Peer Reviewer 4 Discussion/Conclu sion The discussion and conclusion section are clearly written. … In the Discussion, we highlight evidence gaps in the current literature. … Please provide at least a brief discussion on this matter.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_disposition-comments.pdf
    January 01, 2010 - Also presented in our discussion section. … Discussion/ Conclusion 3. … Thank you for your comment, this was already in our discussion section. … #3 Discussion/ Conclusion The report clearly identifies unanswered issues. … this review are clearly stated in the Discussion section.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - Important finding - would say more in discussion. … TEP Reviewer 2 Discussion Furthermore, in the discussion or conclusions, some commentary on specific … Peer Reviewer 4 Discussion Future research section v good Thank you. … TEP Reviewer 8 Discussion Implications are clearly stated and appropriate. … We updated the discussion to include these points.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
    November 15, 2011 - in the discussion of the intervention. … J Bone Miner Res 2008; 23: 1318-25, in the discussion of safety issues. … We have added this reference in our discussion of safety issues in the Findings section. … Some discussion about using pQCT techniques here is merited. … We have added discussion of these points.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
    September 01, 2011 - An expanded discussion of the clinical implications of the main findings might increase the value of … We have expanded our discussion in response to this suggestion, however it must be kept in mind that … We can add more to the discussion. … Reviewer 2 Discussion / KQ1 47 The issue is lack of information, not known disparities. … We have added text to the discussion about the role of industry funding.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - Discussion/ conclusion Very good Noted, thank you. … I would incorporate these important concepts and concepts into the Discussion. … Discussion/C onclusion The discussion and conclusion provide a good summary of the available evidence … We have taken the time to synthesize the results in our discussion chapter. … This is mentioned in the discussion for one study, but what about others.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
    August 12, 2016 - Peer Reviewer #1 Discussion/ Conclusion I don't thnk the conclusions and future research sections … TEP #1 Discussion/ Conclusion The discussion provides conservative inferences of the analysis and … We have added a few sentences to this effect in the Limitations section of the Discussion in the … Peer Reviewer #3 Discussion/ Conclusion Discussion and conclusion is fine, except that I would like … Discussion on implications are reasonable. The limitations as considered are adequate.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
    April 01, 2011 - However, we did want to point out that the study appears to neglect a discussion of long-term proton … In addition, in the discussion of surgical complications in the executive summary, the authors only … in the Executive Summary (Page ES-14) and Discussion (page 154). … Peer Reviewer #1 Discussion Well handed. Thank you for your comments. … Weiglein; Takeda Pharmaceuticals North America, Inc Discussion 1.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - We have noted this in the Discussion section of the report. … We have made several changes to the Discussion section of the report. … This has been noted in the Discussion section of the report. … Peer Reviewer #1 Discussion/ Conclusion I am in agreement with the authors’ discussion/conclusions … Peer Reviewer #10 Discussion/ Conclusion Yes.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
    November 01, 2010 - We have expanded our discussion of this study under KQ2. … Discussion A discussion of how many studies there are and how few even met standards for inclusion seems … Discussion Some discussion of likely roadblocks in doing better research (need for large samples? … Discussion It may be worthwhile to include some of the data in the Discussion section in the Executive … Discussion The findings of this limited review are clearly stated.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - Peer Reviewer 1 Discussion e. … Peer Reviewer 2 Discussion e. Discussion/ Conclusion: See general comments No response necessary. … Peer Reviewer 3 Discussion e. … Peer Reviewer 4 Discussion e. … TEP Reviewer 2 Discussion e.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: